Observational studyPediatric nephrology (Berlin, Germany)2026
Machine learning prediction of childhood nephrotic syndrome outcomes.
Observational study in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildren with steroid-resistant, frequently relapsing, and steroid-dependent nephrotic syndrome experience high disease and treatment-related morbidity. There are few prediction models for childhood nephrotic syndrome outcomes. Our aim was to develop and internally validate outcome prediction models, using machine learning methods.
methodsWe analyzed data from Insight into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics, a prospective observational childhood nephrotic syndrome cohort. We included children (1-18 years) diagnosed from 1996 to 2023 from the Greater Toronto Area, Canada, with baseline data from within 90 days of diagnosis. Outcomes were frequent relapses or steroid dependence by 1 year, relapse occurrence by 1 year, steroid-sparing medication initiation by 2 years, and initial steroid resistance. We developed and compared the performance of nine different machine learning algorithms for each outcome. Predictors included sociodemographic, clinical, and laboratory features.
resultsWe included 515 children diagnosed with nephrotic syndrome. Of these, 484 (94%) were steroid-sensitive and 31 (6%) were steroid-resistant. Nine machine learning models were developed and optimized by hyperparameter tuning for each outcome. The random forest model had the best performance for predicting frequent relapses or steroid dependence, although its predictive ability was low (AUC 0.60). Machine learning models also had weak predictive ability for relapse occurrence (AUC 0.62; logistic regression with recursive feature elimination), steroid-sparing medication initiation (AUC 0.61; XGBoost), and steroid resistance (AUC 0.64; XGBoost).
conclusionsRoutinely collected sociodemographic, clinical, and laboratory features at nephrotic syndrome diagnosis are weakly predictive of subsequent relapses and treatment response, using machine learning methods. Discovery of novel biomarkers may improve future prediction and proactive treatment.
Indexed as
Identifiers
42283830What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.